Alert

Aurora Cannabis Inc. (ACB)

NasdaqCM: ACB · Real-Time Price · USD

3.60

-0.08 (-2.17%)

At close: Aug 17, 2026, 3:59 PM

3.47

-3.49%

Pre-market: 4:00 AM

-2.17% (1D)

Bid	n/a
Market Cap	222.99M
Revenue (ttm)	314.07M
Net Income (ttm)	-52.47M
Beta	1.34
EPS (ttm)	-0.65
PE Ratio (ttm)	n/a
Forward PE	-32.73
P/B (ttm)	0.60
P/S (ttm)	0.71
Earnings Date	Nov 4, 2026

Ask	n/a
Volume	1,522,775
Avg. Volume (20D)	1,319,257
Open	3.65
Previous Close	3.68
Day's Range	3.59 - 3.75
52-Week Range	2.56 - 6.67
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About ACB

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers...

Sector Healthcare

IPO Date Jul 15, 2014

Employees 1,028

Stock Exchange NasdaqCM

Ticker Symbol ACB

Website https://www.auroramj.com

Full Company Profile

Financial Performance

In 2026, Aurora Cannabis's revenue was 320.59M, an increase of 10.97% compared to the previous year's 288.91M. Earnings were -135.96M, a decrease of -8,645.82%.

Financial Statements

Earnings Surprise

Aurora Cannabis has released their quarterly earnings on Aug 5, 2026:

Revenue of $67.55M misses estimates by $0, with -8.80% YoY decline.

EPS of -0.07 exceeds estimates by 0.14, with 74.07% YoY growth.

Next Earnings Release

Aurora Cannabis Inc. is scheduled to release its earnings on Nov 4, 2026, before market opens.
Analysts project revenue of ... Upgrade

News

2 days ago · Motley Fool

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?

Cannabis consolidation appears to be accelerating.

4 days ago · Moby

Curaleaf CEO Defends Hostile Aurora Bid: “We Wanted To Be Friendly”

Curaleaf CEO Boris Jordan says he tried to play nice before taking its $4-per-share Aurora bid public. “We wanted to be friendly,” he said in an interview.